Top compounds associated with response to VTN


Feature Type Standardized
Nominal ANOVA
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.033 0.4
mRNA Merck60 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.035 0.4
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA RG-108 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA MGCD-265 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.031 0.4
Download CSV